Thus, the inhibition of miR-34a by reducing Crtc2 activity in the liver could be beneficial in combating obesity and insulin resistance by promoting whole-body energy metabolism in an Fgf21-dependent manner. The gene discussed is FGF21; the disease is Obesity.